CYBER CODE RED

Get real-time updates on Telegram

P4

CVE-2026-52866: Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0

CVE-2026-52866. CVSS 3.1 base score 6.5 (MEDIUM, Vendor/CNA). EPSS 0.00348 (percentile 0.28089), scored 25-Oct-2026.

Affected technology

Blood Glucose Monitoring System (Model No. APG-01 BT) · 0x0110_v1.1.0
Apollo Pharmacy

Component: Not specified by the source

Attack conditions (Vendor/CNA, CVSS 4.0): Adjacent network · No privileges required · No user interaction required

What an attacker can do

Vendor/CNA’s CVSS 4.0 assessment (base score 7.1/10) rates confidentiality and integrity impact as none; availability impact as high. The description does not specify what an attacker can achieve beyond these rated impacts.

Published

CWE
CWE-862
CCR priority
26.1 /100 (P4)
CVSS 3.1
6.5 /10 · CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H · Vendor/CNA
EPSS
0.00348 · percentile 0.28786 · 2026-11-15
KEV
no

Provenance

Stable permalink: https://cybercodered.org/item/cve-cve-2026-52866.html